All Articles

Appili Therapeutics lands a $40M deal to fight fungal threats, but with cash reserves low and loans due, can its science outpace its financial pressures?

A federal agency's safety warning has sparked a high-stakes legal fight, pitting a small business against regulators in a battle over science and survival.

FDA approval for new 6- and 24-count NARCAN packs aims to streamline distribution for first responders and public health groups on the front lines.

The firm behind a controversial drug-permissive sporting event is hitting Wall Street via a SPAC, challenging the ethics of global anti-doping standards.

Home prices see modest gains, but rising incomes and balanced inventory are shifting the power back to homebuyers for the first time since the pandemic.

Tucows announced a new $40M stock buyback, but investor concerns over its strategic pivot and debt overshadow the move, pushing shares lower.

Vitalist reports soaring losses and a $6.4M debt surge, raising 'going concern' alarms. Can its new Reebok smartwatches and VitalOS™ platform save it?

Cohen & Co.-backed SPAC joins the hunt for a merger target, highlighting a renewed investor appetite for blank check companies in a maturing market.

The Texas retailer will be the first tenant in the massive 217-acre mixed-use project, signaling a new era of experiential retail in booming North Texas.

The aviation firm renews its share buyback program, a move backed by a stronger balance sheet and a strategic pivot to higher-margin services.

As new federal rules banning replacement workers reshape labour disputes, Ottawa has appointed six vice-chairpersons to the heavily burdened CIRB.

The wealth management giant reports record earnings and massive client inflows, signaling confidence and a focus on shareholder returns in a competitive market.

Weatherford deepens its partnership with TotalEnergies, landing a crucial multi-year deal to support Denmark's offshore energy infrastructure.

With a record 21st NMMA CSI Award, Tigé Boats isn't just winning trophies; it's redefining long-term owner loyalty in the competitive marine industry.

With strong financials and a focus on tech, Allegion's CEO will outline the security giant's long-term strategy for a digitally connected world.

SkyMD's new virtual therapy service targets New Mexico's deep provider shortages and access issues, but enters a competitive and complex digital market.

With top executives set for major conferences, investors eye Mastercard's playbook for commercial payments and Americas growth amid fierce competition.

Anebulo Pharmaceuticals is delisting from Nasdaq to focus on a pediatric cannabis antidote, leaving investors to grapple with an uncertain future.

In a strategic move, Central Garden & Pet appoints former exec Kay Schwichtenberg to its board, signaling a focus on animal health and institutional knowledge.

With a 33% revenue surge and expanding margins, Capstone Green Energy's strategic pivot to data centers and EaaS is paying off, marking a major turnaround.